Literature DB >> 7195531

Determination of ovarian function using first morning urine steroid assays.

J H Denari, Z Farinati, P R Casas, A Oliva.   

Abstract

A new direct radioimmunoassay measuring ovarian steroid metabolites in small aliquots of urine has been evaluated. For this purpose urinary levels of estrone-3-glucuronide (E1G) and pregnanediol-3-glucuronide (PG) were correlated with plasma values of estradiol (E2) and progesterone (P), respectively, from days 5 to 24 of the cycle in 24 women with normal cycles. Urine samples were representative of 1) first morning voiding; 2) 24-hour collection; and 3) all voidings except for the first morning one. The correlation between urinary E1G and PG with plasma values of E2 and P was statistically significant for the 3 collections of urine. The first morning voiding is selected as the sample of choice to determine E1G and PG due to its ease of collection and its high correlation with plasma E2 and P levels (r = .60, P less than .001; r = .73, P less than .001, respectively).

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7195531

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  13 in total

1.  Comparability of serum, plasma, and urinary estrogen and estrogen metabolite measurements by sex and menopausal status.

Authors:  Sally B Coburn; Frank Z Stanczyk; Roni T Falk; Katherine A McGlynn; Louise A Brinton; Joshua Sampson; Gary Bradwin; Xia Xu; Britton Trabert
Journal:  Cancer Causes Control       Date:  2018-12-01       Impact factor: 2.506

2.  Sleep symptoms during the menopausal transition and early postmenopause: observations from the Seattle Midlife Women's Health Study.

Authors:  Nancy Fugate Woods; Ellen Sullivan Mitchell
Journal:  Sleep       Date:  2010-04       Impact factor: 5.849

3.  Endocrine biomarkers and symptom clusters during the menopausal transition and early postmenopause: observations from the Seattle Midlife Women's Health Study.

Authors:  Nancy Fugate Woods; Lori Cray; Ellen Sullivan Mitchell; Jerald R Herting
Journal:  Menopause       Date:  2014-06       Impact factor: 2.953

4.  Association of estrogen measurements in serum and urine of premenopausal women.

Authors:  Gertraud Maskarinec; Fanchon Beckford; Yukiko Morimoto; Adrian A Franke; Frank Z Stanczyk
Journal:  Biomark Med       Date:  2015       Impact factor: 2.851

5.  Cortisol levels during the menopausal transition and early postmenopause: observations from the Seattle Midlife Women's Health Study.

Authors:  Nancy Fugate Woods; Ellen Sullivan Mitchell; Kathleen Smith-Dijulio
Journal:  Menopause       Date:  2009 Jul-Aug       Impact factor: 2.953

6.  Constipation and diarrhea during the menopause transition and early postmenopause: observations from the Seattle Midlife Women's Health Study.

Authors:  Nini G L Callan; Ellen S Mitchell; Margaret M Heitkemper; Nancy F Woods
Journal:  Menopause       Date:  2018-06       Impact factor: 2.953

7.  Is the menopausal transition stressful? Observations of perceived stress from the Seattle Midlife Women's Health Study.

Authors:  Nancy Fugate Woods; Ellen Sullivan Mitchell; Don B Percival; Kathleen Smith-DiJulio
Journal:  Menopause       Date:  2009 Jan-Feb       Impact factor: 2.953

8.  Sexual desire during the menopausal transition and early postmenopause: observations from the Seattle Midlife Women's Health Study.

Authors:  Nancy Fugate Woods; Ellen Sullivan Mitchell; Kathy Smith-Di Julio
Journal:  J Womens Health (Larchmt)       Date:  2010-02       Impact factor: 2.681

9.  The use of biochemical assays in epidemiologic studies of reproduction.

Authors:  A J Wilcox; D D Baird; C R Weinberg; E G Armstrong; P I Musey; R E Wehmann; R E Canfield
Journal:  Environ Health Perspect       Date:  1987-11       Impact factor: 9.031

10.  Using reproductive effect markers to observe subclinical events, reduce misclassification, and explore mechanism.

Authors:  M C Hatch; G Friedman-Jimenez
Journal:  Environ Health Perspect       Date:  1991-01       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.